Delcath Systems Announces Second Quarter 2021 Results
NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today reported business highlights and financial results for…
